Ignite Creation Date:
2024-05-06 @ 10:14 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03208972
Status:
COMPLETED
Last Update Posted:
2021-02-03
First Post:
2014-05-07
Brief Title:
Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG
Sponsor:
AZ Jan Palfijn Gent
Organization:
AZ Jan Palfijn Gent
Study Overview
Official Title:
Prospective Randomized Trial Comparing Ovarian Stimulation in IVF-patients With Corifollitropin Alfa in Combination With Hp-FSH Versus Corifollitropin Alfa in Combination With Low Dose hCG
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study compares in a randomized controlled way two stimulation methods One of these stimulation methods implements a new insight in ovarian follicular growth If this novel method of stimulation proves to be as efficient as the classical stimulation protocols there might be a dramatic reduction of the costs of the medical therapy in IVF thus reducing also the overall IVf costs significantly
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None